Andrea Natale, M.D. from Cleveland Clinic Heart Center Joins Recom's Medical Advisory Board.

STUDIO CITY, Calif. -- Recom Managed Systems, Inc. (OTCBB:RECM), a leader in innovative design and development of ambulatory medical devices containing the company's proprietary signal processing technology, announced today that Andrea Natale, M.D., Co-Section Head of Pacing and Electrophysiology at The Cleveland Clinic Foundation and Medical Director, Center for Atrial Fibrillation as well as Director, Electrophysiology Laboratories at Cleveland Clinic Heart Center, will be joining Recom's Medical Advisory Board.

Dr. Natale has had a very distinguished career in the field of Cardiology. He brings to Recom over 18 years in professional and academic experience in Cardiology as well as consultation experience at some of the largest medical device companies. Dr. Natale is also a Member of the North American Society of Pacing and Electrophysiology.

"We are delighted to welcome Dr. Natale, internationally known electrophysiologist, to Recom's Medical Advisory Board," commented Budimir S. Drakulic, Ph.D., Recom's Chief Scientist and CTO. "With his expertise, insight and leadership in clinical cardiac electrophysiology, Recom looks forward to the contributions Dr. Natale will make as we move into the evaluation phase of our 24/7 ambulatory heart monitoring system."

"Recom is excited to have Dr. Natale working with us in guiding the best way to implement our patented signal processing technology to clinical practice," commented James J. Mazeika, Recom's Director of Business Development.

About Recom Managed Systems

Recom Managed Systems, Inc. is an emerging life sciences company focused on the monitoring and detection of disease through continuous biomedical signal monitoring. Recom Managed Systems, Inc. uses its patented signal technology to design and develop medical devices that simplify and reduce the costs of diagnostic testing and patient monitoring in an ambulatory setting. With our patented signal technology platform, Recom brings clinical quality physiological signal monitoring to the ambulatory setting.

Statements in this release that are not strictly historical are "forward-looking" statements. Forward-looking statements involve known and unknown risks, which may cause Recom's actual results in the future to differ materially from expected results. Factors which could cause or contribute to such differences include, but are not limited to failure to complete the development and introduction of new products or services, failure to obtain federal or state regulatory approvals governing medical devices, monitoring and other related services or products, inability to obtain physician, patient or insurance acceptance of Recom's products or services, adverse equity market conditions and declines in the value of Recom's common stock, and the unavailability of financing to complete management's plans and objectives. These risks are qualified in their entirety by cautionary language and risk factors set forth and to be further described in Recom's filings with the Securities and Exchange Commission.